| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | +0.0% |
| R&D Expense | $6.8M | +28.3% |
| SG&A Expense | $5.5M | +4.5% |
| Operating Income | -$12.7M | -28.0% |
| Pre-tax Income | -$11.0M | -28.9% |
| Income Tax | $6K | +81.7% |
| Net Income | -$11.0M | -28.9% |
| EPS (Basic) | -$0.23 | -35.3% |
| EPS (Diluted) | -$0.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.4M | -20.9% |
| Current Assets | $41.1M | -19.7% |
| Total Assets | $55.9M | -15.7% |
| Current Liabilities | $3.0M | -9.8% |
| Total Liabilities | $3.4M | -13.3% |
| Stockholders' Equity | $52.5M | -15.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.6M | -43.2% |
| Capital Expenditures | $895 | -95.8% |
| Investing Cash Flow | -$697 | -100.0% |
| Free Cash Flow | -$10.6M | -42.8% |
| -35.3% |